Navigation Links
Harbinger Research Initiates Coverage on HearAtLast
Date:10/26/2007

TORONTO, Oct. 26 /PRNewswire-FirstCall/ -- HearAtLast, Inc., (Pink Sheets: HRAL) announced today that Harbinger Research LLC has initiated research coverage on the company. HearAtLast, Inc. The research report provides an investment rating, price target, and earnings model, in addition to a summary of the Company as an investment opportunity, an overview of its businesses, its sales and marketing strategy, and a discussion of the company's industry. To read the report please visit:

(Due to URL length, please copy and paste into your browser.)

http://harbingerresearch.com/reports/2007-10-

26_HearAtLast_HarbingerResearchCoverage.pdf

Harbinger Research was contracted by the company to author the research report for the purpose of increasing investor awareness and informing both institutional and individual investors of the investment potential of the Company.

About Harbinger Research

Harbinger Research is a New York based independent equity research company. They provide equity research coverage to smaller U.S. traded companies and the individuals and institutions who invest in them. For more information on Harbinger Research, please visit http://www.harbingerresearch.com

About HearAtLast, Inc.

HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

Forward-Looking Statements

Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. These risks, assumptions and uncertainties include: the ability to complete systems within currently estimated time frames and budgets; the ability to compete effectively in a rapidly evolving and price competitive marketplace; changes in the nature of telecommunications regulation in the United States and other countries; changes in business strategy; the successful integration of newly acquired businesses; the impact of technological change; and other risks referenced from time to time in the Company's filings with the Securities and Exchange Commission.

Investor Relations:

Stephen Taylor

Taylor Capital, Inc.

Phone: 973-351-3868

E-Mail: STEPHTAYL9@AOL.COM


'/>"/>
SOURCE HearAtLast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Attention Breakdown Is The Harbinger Of Alzheimers Disease
2. Severe Cold is Harbinger of Infections
3. Harbinger of Hope for Kala Azar Victims of Bihar
4. Kidney Stones - Interesting New Research implicates bacteria as its cause
5. Stem cell research- now Nobel Laureates join the debate
6. Researchers urge caution in using ear tube surgery
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Spouses and other partners lower blood pressure says new research
9. Researchers Scale to assess the Severity of Epilepsy in Kids
10. More Research Required For COPD
11. Researchers identify the early makers of Neonatal Sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: